TrialBlood advances2025

Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study.

Ali T Taher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.